- Why, as stated
- Cutting costsRestructuring or new strategy
“three-year plan to save £1.9 billion”
Talent Risk · Employers · Pharma & healthcare
GSK is showing signs of job cuts.
Reported, not yet confirmed: one major outlet. Latest, on 14th October: GSK announced potential cuts of up to 1,217 jobs in Belgium as part of a three-year restructuring plan to save £1.9 billion.
For scale: at the UK redundancy rate (4.0 per 1,000 employees in June to August 2026, ONS), an employer of 68,000 people would see about 1,100 redundancies a year. This record counts only cuts announced publicly or filed as a formal notice. ONS
GSK to cut 1,217 jobs
GSK announced potential cuts of up to 1,217 jobs in Belgium as part of a three-year restructuring plan to save £1.9 billion.
BelgiumOne major outlet so far: Reuters · 3 sources in allEvery source →
GSK to cut 641 jobs
GSK announced closure of its vaccine factory in Germany, putting 641 jobs at risk.
GermanyOne major outlet so far: Reuters · 2 sources in allEvery source →
Which jobs Factory and production · Research and development
Why, as stated Cutting costs · Restructuring or new strategy · Closing sites or units
Next This becomes Cutting if the company, a formal notice or a second major outlet confirms cuts.
Out of the ordinary. 1.8% of its workforce in 90 days — nothing comparable recorded in the previous nine months.
This label is our opinion, reached by applying one published rule to the sources listed. GSK can correct the record at any time.
| Label | Signs since the week to 21st Nov |
|---|---|
| Jobs in announced cuts, 90 days and 12 months | 1,217 · 1.8% of about 68,000 staff |
| Latest on the record | 14th October 2026 · Cuts announced · 1,217 jobs |
| Jobs named in cuts | Factory and production · Research and development |
| Hiring or redeploying into | Research and development |
| Where the jobs are | Stevenage · Ware · Cambridge · Wavre · Belgium, Germany, UK |
| Why, as stated | Cutting costs · Restructuring or new strategy · Closing sites or units |
| Jobs we count | 1,217 of the 2,258 jobs reported, each round once; not counted: 1,041 in 2 figures: figure given by one report only. How we count |
| Normal for them? | Out of the ordinary. 1.8% of its workforce in 90 days — nothing comparable recorded in the previous nine months. |
| Sources, 12 months | 20 reports from 11 outlets, each linked below |
| Headquarters · sector | UK · Pharma & healthcare · GSK |
| Which company | GSK plc (formerly GlaxoSmithKline), the UK pharmaceutical company. Not Haleon. |
Identifiers Wikidata Q212322 · LEI 5493000HZTVUYLO1D793 · SEC CIK 0001131399 · Companies House 03888792 · ISIN GB0009252882 · GSK on London Stock Exchange · GSK on New York Stock Exchange · About these
A formal notice counts here when it is filed by one of GSK’s own legal entities, named exactly as below. Names two employers both claim are left out. How we match
GLEIF register · source
SMITHKLINE BEECHAM PHARMA GMBH & CO. KG · GLAXO WELLCOME SA · GLAXOSMITHKLINE BIOLOGICALS · GLAXOSMITHKLINE BIOLOGICALS GYÓGYSZERGYÁRTÓ ÉS FORGALMAZÓ KORLÁTOLT FELELŐSSÉGŰ TÁRSASÁG · GLAXOSMITHKLINE BIOLOGICALS KFT. · GLAXO WELLCOME PRODUCTION · GSK VACCINES GMBH · CORIXA CORPORATION · GLAXO OPERATIONS UK LIMITED · GLAXOSMITHKLINE VACCINES S.R.L. · GSK VACCINES SRL · GLAXOSMITHKLINE MANUFACTURING S.P.A. · STIEFEL LABORATORIES LEGACY (IRELAND) LIMITED · 14245563 CANADA INC. · GLAXOSMITHKLINE LIMITED · 葛蘭素史克有限公司 · ID BIOMEDICAL CORPORATION OF QUEBEC · CORPORATION ID BIOMÉDICAL DU QUÉBEC · جي إس كيه لايف ساينسز م م ح · BELLUS HEALTH INC. · BELLUS SANTÉ INC. · GLAXO WELLCOME UK LIMITED · VIIV HEALTHCARE LIMITED · VIIV HEALTHCARE UK (NO.3) LIMITED · and 39 more in the register
Wikidata · source
GlaxoSmithKline (Spain) · GlaxoSmithKline (Germany) · GlaxoSmithKline (Italy) · GlaxoSmithKline (Belgium) · GlaxoSmithKline (Croatia) · GlaxoSmithKline (Ireland) · GlaxoSmithKline (United States) · GlaxoSmithKline (Canada) · GlaxoSmithKline (Australia) · GlaxoSmithKline (Poland) · GlaxoSmithKline (Sri Lanka) · Stiefel Laboratories · GlaxoSmithKline (Japan) · GlaxoSmithKline Turkey
Every event on the record, newest first. Each has its own page; open a row’s reports to see every source. How we decide
GSK announced potential cuts of up to 1,217 jobs in Belgium as part of a three-year restructuring plan to save £1.9 billion.
Reuters Major outlet
GSK announced plans to cut up to 1,217 jobs in Belgium as part of a three-year restructuring plan.
finance.yahoo.com Trade press
GSK plans up to 1,217 job cuts in Belgium.
finance.yahoo.com Trade press
GSK plans up to 1,217 job cuts in Belgium.
Fierce Biotech Trade press
GSK announced up to 1,217 job losses in Belgium as part of global cost-saving plans.
Fierce Biotech Trade press
GSK announced layoffs of over 1,200 roles in Belgium as part of its cost-saving program.
hr.economictimes.indiatimes.com Trade press
GSK announced up to 1,217 job cuts in Belgium.
Reuters Major outlet
GSK announced potential cuts of up to 1,217 jobs in Belgium as part of a three-year restructuring plan to save £1.9 billion.
finance.yahoo.com Trade press
GSK is planning up to 1,217 job cuts in Belgium.
pharma.economictimes.indiatimes.com Trade press
GSK announced plans to cut up to 1,217 jobs in Belgium as part of a three-year restructuring plan.
GSK announced closure of its vaccine factory in Germany, putting 641 jobs at risk.
Reuters Major outlet
GSK announced closure of its vaccine factory in Germany, putting 641 jobs at risk.
finance.yahoo.com Trade press
GSK announced closure of its vaccine factory in Germany, putting 641 jobs at risk.
Fierce Pharma Trade press
GSK announced closure of its German flu vaccine manufacturing site, described as a difficult decision.
finance.yahoo.com Trade press
GSK plans to close its vaccine manufacturing facility in Dresden, Germany, by summer 2027, putting 641 jobs at risk. The company is consolidating flu vaccine production to its Canada site.
finance.yahoo.com Trade press
GSK announced 641 job cuts in vaccine manufacturing as part of a restructuring initiative.
GSK announced job cuts as part of a £1.9bn cost-cutting programme to fund a £400m UK life sciences investment, including a new Cambridge R&D centre.
The Guardian Major outlet
GSK announced job cuts as part of a £1.9bn cost-cutting programme to fund a £400m UK life sciences investment, including a new Cambridge R&D centre. The company will close its Stevenage R&D site by 2029 and move over 1,000 scientists to Cambridge.
GSK announced a $2.5 billion restructuring programme to accelerate new drug development and raise margin outlook.
Reuters Major outlet
GSK announced a $2.5 billion restructuring programme to accelerate new drug development and raise margin outlook.
Business Journals Trade press
GSK unveiled a $2.5B cost-cutting plan in response to anticipated patent cliff challenges.
GSK announced closure of its historic Stevenage research site with relocation of research centre to Cambridge.
Financial Times Major outlet
GSK announced closure of its historic Stevenage research site with relocation of research centre to Cambridge.
City A.M. Trade press
GSK announced sweeping job cuts to fund a £400m Cambridge campus investment.
GSK cut 400 jobs in Belgium during 2025.
VRT Major outlet
GSK cut 400 jobs in Belgium during 2025.
Official documents only (US WARN notices and SEC filings) filed for GSK since 2025. They are shown as filed, one row per document: a round notified at several sites appears once per site. They never change the label, which reads the last 90 days.
| Year | Documents | Jobs they state |
|---|---|---|
| 2025 | 2 | 158 |
“three-year plan to save £1.9 billion”
“GSK reviewed its Dresden and Ste-Foy, Canada, flu vaccine sites and chose to consolidate production in Canada, which it says can meet anticipated demand more sustainably and competitively.”
“sweeping job cuts as part of a £1.9bn cost-cutting programme to pay for a £400m investment in UK life sciences”
Only what the sources say. If no report gives a reason, we don’t suggest one.
| 21st Nov | Cutting → Signs · Reported, not yet confirmed: one major outlet |
|---|---|
| 12th Sep | Signs → Cutting · Confirmed: 2 major news outlets report job cuts |
| 1st Aug | Quiet → Signs · Not yet cuts: buyouts offered or a restructuring charge booked; no job cuts confirmed |
| 11th Jul | Signs → Quiet · Nothing qualifying in the last 180 days |
44%
of the 2,749 job cuts announced in 12 months by the employers we rate in pharma & healthcare.
Job cuts in 12 months as a share of each employer’s workforce.
GSK can reply or correct this record at any time.
This label is our opinion, reached by applying one published rule to the sources listed.